BluGlass Limited (ASX:BLG) Advances GaN Laser Programs as New Funding Supports Product Development

Aditi Sarkar

11 November 2026 02:52 PM AEDT

BluGlass Limited (ASX:BLG) Advances GaN Laser Programs as New Funding Supports Product Development

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

BluGlass secured an AUD 8 mn Research and Development financing Facility in September 2026.
A Phase II development contract with Uviquity was announced in July, valued at approximately AUD 1.4 mn.
The company is developing visible gallium nitride lasers for specialist industrial and technology applications.
BluGlass published its September-quarter update and 2026 Annual Report before the November reporting cutoff.

BluGlass Limited (ASX:BLG) is advancing specialist gallium nitride laser work through a customer development program and newly arranged research financing.

Research Funding Backs Development Work

BluGlass announced an AUD 8 mn research and development financing facility in September 2026, replacing a smaller existing facility. The arrangement provides a funding mechanism for eligible development activities; it should not be confused with sales revenue.

Research funding and customer contracts play different roles in the semiconductor company’s operating model.

Customer Collaboration Enters Phase II

In July 2026 BluGlass announced a Phase II program with Uviquity under an existing joint development agreement. The phase was valued at approximately AUD 1.4 mn.

The agreement provides an identified customer development milestone, but completion, payment timing and any subsequent phases depend on the relevant contractual and technical requirements.

Visible Lasers Remain the Core Technology

BluGlass develops and manufactures visible gallium nitride, or GaN, laser devices. Its technology work spans semiconductor fabrication and associated laser development for specialist applications.

The company presents itself as a vertically integrated supplier. Commercial progress therefore involves both delivering customer engineering programs and moving products through technical qualification into repeatable production.

Reporting and Next Steps

BluGlass released its annual report for FY26 in August and a quarterly activities report for September 2026 in October. The company also participated in semiconductor industry events to present its technology.

Near-term priorities include progressing contracted development programs and managing the technical and commercial requirements of GaN laser production. Future orders and further project phases must be confirmed through company announcements before they can be treated as revenue.

BluGlass shares traded at AUD 0.17 on 11 November 2026, unchanged, with a Market Capitalisation of approximately AUD 32.8 mn.

FAQs

Q: What technology does BluGlass develop?

A: Visible gallium nitride semiconductor lasers.

Q: How much was the Uviquity Phase II contract?

A: Approximately AUD 1.4 mn.

Q: What financing did BluGlass announce?

A: An AUD 8 mn research and development funding facility.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.